Intellipharmaceutics International Inc. (IPCIF)

USD 0.15

(N/A%)

Revenue Summary of Intellipharmaceutics International Inc.

  • Intellipharmaceutics International Inc.'s latest annual revenue in 2023 was 65.72 Thousand USD , down 0.0% from previous year.
  • Intellipharmaceutics International Inc.'s latest quarterly revenue in 2024 Q2 was 480.2 Thousand USD , up 47.15% from previous quarter.
  • Intellipharmaceutics International Inc. reported a annual revenue of 65.72 Thousand USD in annual revenue 2022, down -95.31% from previous year.
  • Intellipharmaceutics International Inc. reported a annual revenue of 1.4 Million USD in annual revenue 2021, down 0.0% from previous year.
  • Intellipharmaceutics International Inc. reported a quarterly revenue of 68.71 Thousand USD for 2024 Q3, down -85.69% from previous quarter.
  • Intellipharmaceutics International Inc. reported a quarterly revenue of 480.2 Thousand USD for 2024 Q2, up 47.15% from previous quarter.

Annual Revenue Chart of Intellipharmaceutics International Inc. (2023 - 1997)

Historical Annual Revenue of Intellipharmaceutics International Inc. (2023 - 1997)

Year Revenue Revenue Growth
2023 65.72 Thousand USD 0.0%
2022 65.72 Thousand USD -95.31%
2021 1.4 Million USD 0.0%
2020 1.4 Million USD -18.17%
2019 1.71 Million USD -68.88%
2018 5.5 Million USD 144.97%
2017 2.24 Million USD -45.11%
2016 4.09 Million USD -53.32%
2015 8.76 Million USD 474.13%
2014 1.52 Million USD 1326.33%
2013 107.09 Thousand USD -78.66%
2012 501.81 Thousand USD -65.61%
2011 1.45 Million USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%
2004 - USD 0.0%
2003 - USD -100.0%
2002 1000.03 USD 0.02%
2001 999.82 USD -99.0%
2000 100.05 Thousand USD 0.22%
1999 99.83 Thousand USD 42.07%
1998 70.27 Thousand USD -5.31%
1997 74.21 Thousand USD 0.0%

Peer Revenue Comparison of Intellipharmaceutics International Inc.

Name Revenue Revenue Difference
Burzynski Research Institute, Inc. - USD -Infinity%
Arch Therapeutics, Inc. 75.72 Thousand USD 13.201%
Evofem Biosciences, Inc. 18.21 Million USD 99.639%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 99.947%
Qrons Inc. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
Neon Bloom, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 1.93 Million USD 96.598%
ProtoKinetix, Incorporated - USD -Infinity%
Skye Bioscience, Inc. - USD -Infinity%
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 99.583%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD -273.009%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 21.47 Million USD 99.694%
Propanc Biopharma, Inc. - USD -Infinity%
Mesoblast Limited 5.9 Million USD 98.886%
Marizyme, Inc. 645.81 Thousand USD 89.822%
Genus plc 668.8 Million USD 99.99%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.973%
Therapeutic Solutions International, Inc. 98.99 Thousand USD 33.604%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD 83.975%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD 14.373%
IMV Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 39.51 Thousand USD -66.324%
MultiCell Technologies, Inc. 49.32 USD -133168.451%
ONE Bio Corp. 52.29 Million USD 99.874%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 49.72 Million USD 99.868%
Arno Therapeutics, Inc. - USD -Infinity%
EV Biologics, Inc. 48.9 Thousand USD -34.413%
Q BioMed Inc. 284.35 Thousand USD 76.885%
Emmaus Life Sciences, Inc. 29.59 Million USD 99.778%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 99.955%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD 88.215%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Oncotelic Therapeutics, Inc. 70 Thousand USD 6.103%
GlobeStar Therapeutics Corporation - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 658.5 Thousand USD 90.019%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 14.69 Billion USD 100.0%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 999.00 USD -6479.379%
Enzolytics Inc. 52.79 Thousand USD -24.494%
Agentix Corp. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 608.52 Thousand USD 89.199%
MetaStat, Inc. - USD -Infinity%
argenx SE 1.22 Billion USD 99.995%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. 140.24 Thousand USD 53.132%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD 89.354%
Zenith Capital Corp. - USD -Infinity%
Genscript Biotech Corporation 839.52 Million USD 99.992%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. - USD -Infinity%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Kadimastem Ltd - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD 93.412%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 48.35 Million USD 99.864%
BioStem Technologies, Inc. 16.68 Million USD 99.606%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD 72.215%
Regen BioPharma, Inc. 236.56 Thousand USD 72.215%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. 1.36 Million USD 95.199%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD 86.125%
SYBLEU INC 11.69 Thousand USD -461.97%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 99.156%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD -405.6%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD -66.257%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 98.026%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 99.014%
IntelGenx Technologies Corp. 1.03 Million USD 93.674%
Gelesis Holdings, Inc. 25.76 Million USD 99.745%
CSL Limited 14.8 Billion USD 100.0%
Cellectis S.A. 755 Thousand USD 91.294%